InsiderClue
Insiders · Profile

Hallal David

Chief Executive Officer at Scholar Rock · Director at Kalaris Therapeutics. Filing since 24 Jan 2022. CIK 0001457477

SRRK Scholar Rock Holding Corp Chief Executive Officer · 2 trades KLRS Kalaris Therapeutics, Inc. Director · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SRRK Scholar Rock Holding Corp
16 Apr 2026
Chief Executive Officer
Sold at will
30,615
$1.52M
1.8%
SRRK Scholar Rock Holding Corp
13 Jan 2026
Chief Executive Officer
Sold at will
57,450
$2.45M
3.6%
KLRS Kalaris Therapeutics, Inc.
19 Oct 2022
Director
Sold, plan not stated
600,000
$5.07M
81.3%
KLRS Kalaris Therapeutics, Inc.
29 Sep 2022
Director
Sold, plan not stated
400,000
$2.94M
35.7%
KLRS Kalaris Therapeutics, Inc.
21 Jul 2022
Director
Sold, plan not stated
4,227
$22.53K
0.2%
KLRS Kalaris Therapeutics, Inc.
3 Jun 2022
Director
Sold, plan not stated
65,725
$241.11K
3.1%
KLRS Kalaris Therapeutics, Inc.
21 Apr 2022
Director
Sold, plan not stated
4,227
$24.81K
0.2%
KLRS Kalaris Therapeutics, Inc.
11 Mar 2022
Director
Sold, plan not stated
25,244
$186.07K
1.2%
KLRS Kalaris Therapeutics, Inc.
10 Mar 2022
Director
Sold, plan not stated
40,481
$305.78K
1.8%
KLRS Kalaris Therapeutics, Inc.
24 Jan 2022
Director
Sold, plan not stated
17,100
$136.89K
0.8%
10 decisions on file.